Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.
about
Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Rectally administered indometh ...... a randomized controlled trial.
@en
Rectally administered indomethacin to prevent post-ESWL-pancreatitis
@nl
type
label
Rectally administered indometh ...... a randomized controlled trial.
@en
Rectally administered indomethacin to prevent post-ESWL-pancreatitis
@nl
prefLabel
Rectally administered indometh ...... a randomized controlled trial.
@en
Rectally administered indomethacin to prevent post-ESWL-pancreatitis
@nl
P2093
P2860
P1433
P1476
Rectally administered indometh ...... a randomized controlled trial.
@en
P2093
Duo-Wu Zou
Liang-Hao Hu
Luo-Wei Wang
Wen-Bin Zou
P2860
P2888
P356
10.1186/S13063-017-2250-7
P577
2017-11-02T00:00:00Z
P6179
1092508562